Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof

US8691817B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Franz Von Nussbaum · Mülheim an der Ruhr, DE
• Dagmar Karthaus · Solingen, DE
• Sonja Anlauf · Wuppertal, DE
• Martina Delbeck · Essen, DE
• Volkhart Min-Jian Li · Velbert, DE
• Daniel Meibom · Leverkusen, DE
• Klemens Lustig · Wuppertal, DE
• Dirk Schneider · Wuppertal, DE

Key dates

• Filing date: Mar 30, 2010
• Grant date: Apr 8, 2014
• Expiry date: Jul 11, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel sulfonamide- or sulfoximine-substituted 1,4-diaryldihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.